280 related articles for article (PubMed ID: 12751265)
1. Clinical pharmacology of antifungal compounds.
Groll AH; Gea-Banacloche JC; Glasmacher A; Just-Nuebling G; Maschmeyer G; Walsh TJ
Infect Dis Clin North Am; 2003 Mar; 17(1):159-91, ix. PubMed ID: 12751265
[TBL] [Abstract][Full Text] [Related]
2. Antifungal treatment in pediatric patients.
Zaoutis TE; Benjamin DK; Steinbach WJ
Drug Resist Updat; 2005 Aug; 8(4):235-45. PubMed ID: 16054422
[TBL] [Abstract][Full Text] [Related]
3. Systemic mycoses in the immunocompromised host: an update in antifungal therapy.
Kontoyiannis DP; Mantadakis E; Samonis G
J Hosp Infect; 2003 Apr; 53(4):243-58. PubMed ID: 12660121
[TBL] [Abstract][Full Text] [Related]
4. Antifungals in Clinical Use and the Pipeline.
Johnson MD
Infect Dis Clin North Am; 2021 Jun; 35(2):341-371. PubMed ID: 34016281
[TBL] [Abstract][Full Text] [Related]
5. Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infections.
Groll AH; Walsh TJ
Expert Opin Investig Drugs; 2001 Aug; 10(8):1545-58. PubMed ID: 11772269
[TBL] [Abstract][Full Text] [Related]
6. Newer antifungal agents.
Abuhammour W; Habte-Gaber E
Indian J Pediatr; 2004 Mar; 71(3):253-9. PubMed ID: 15080413
[TBL] [Abstract][Full Text] [Related]
7. New antifungal drugs and the pediatric cancer patient: current status of clinical development.
Groll AH; Lehrnbecher T
Klin Padiatr; 2005; 217(3):158-68. PubMed ID: 15858708
[TBL] [Abstract][Full Text] [Related]
8. New drugs and novel targets for treatment of invasive fungal infections in patients with cancer.
Chiou CC; Groll AH; Walsh TJ
Oncologist; 2000; 5(2):120-35. PubMed ID: 10794803
[TBL] [Abstract][Full Text] [Related]
9. Antifungal agents: mechanisms of action.
Odds FC; Brown AJ; Gow NA
Trends Microbiol; 2003 Jun; 11(6):272-9. PubMed ID: 12823944
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetics and pharmacodynamics of antifungal drugs in children].
Jullien V
Arch Pediatr; 2011 May; 18 Suppl 1():S42-7. PubMed ID: 21596286
[TBL] [Abstract][Full Text] [Related]
11. Caspofungin acetate for treatment of invasive fungal infections.
Pacetti SA; Gelone SP
Ann Pharmacother; 2003 Jan; 37(1):90-8. PubMed ID: 12503942
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of antifungal agents in children.
Watt K; Benjamin DK; Cohen-Wolkowiez M
Early Hum Dev; 2011 Mar; 87 Suppl 1(Suppl 1):S61-5. PubMed ID: 21277714
[TBL] [Abstract][Full Text] [Related]
13. New antifungal agents.
Graybill JR
Eur J Clin Microbiol Infect Dis; 1989 May; 8(5):402-12. PubMed ID: 2546775
[TBL] [Abstract][Full Text] [Related]
14. Experiences with the use of caspofungin in paediatric patients.
Lehrnbecher T; Groll AH
Mycoses; 2008; 51 Suppl 1():58-64. PubMed ID: 18471162
[TBL] [Abstract][Full Text] [Related]
15. Comment: caspofungin acetate for treatment of invasive fungal infections.
Chan J
Ann Pharmacother; 2003 Apr; 37(4):595. PubMed ID: 12659624
[No Abstract] [Full Text] [Related]
16. Pediatric antifungal agents.
Cohen-Wolkowiez M; Moran C; Benjamin DK; Smith PB
Curr Opin Infect Dis; 2009 Dec; 22(6):553-8. PubMed ID: 19741525
[TBL] [Abstract][Full Text] [Related]
17. New antifungal agents.
Gupta AK; Tomas E
Dermatol Clin; 2003 Jul; 21(3):565-76. PubMed ID: 12956208
[TBL] [Abstract][Full Text] [Related]
18. Antifungal chemotherapy: advances and perspectives.
Groll AH; Walsh TJ
Swiss Med Wkly; 2002 Jun; 132(23-24):303-11. PubMed ID: 12362280
[TBL] [Abstract][Full Text] [Related]
19. Current and future antifungal therapy: new targets for antifungal therapy.
Andriole VT
Int J Antimicrob Agents; 2000 Nov; 16(3):317-21. PubMed ID: 11091055
[TBL] [Abstract][Full Text] [Related]
20. [New systemic antifungal drugs: mechanisms of action, drug interactions and side effects].
Schäfer-Korting M
Mycoses; 2003; 46 Suppl 1():28-31. PubMed ID: 12955850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
